The mechanisms by which hyperglycemia perturbs stem cell proliferation are poorly defined, but may be an adverse effect from disrupted barrier function changing the extracellular milieu with increased exposure to inflammatory cytokines, or it could result from alterations in insulin signaling pathways [58,60]. The gene discussed is INS; the disease is Hyperglycemia.